Type I interferons

International Reviews of Immunology

Volumn 17, Issue 1-4, 1998, Pages 53-73

  De Maeyer, Edward ^a   De Maeyer Guignard, Jaqueline ^a  

^a INSTITUT CURIE   (France)

Author keywords

Antiviral; Cytokines; Double stranded RNA; T cell; Tumor

Indexed keywords

EID: 0032412325     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189809084487     Document Type: Article

References (120)

1. Aguet, M., Vignaux, F., Fridman, W H. and Gresser, I. (1981). Enhancement, of Fcγ receptor expression in interferon-treated mice. Eur. J. Immunol. 11, 926-930.
2. Alber, D. and Staeheli, P. (1996). Partial inhibition of vesicular stomatitis virus by the interferon-induced human 9-27 protein. J. IFN & Cytokine Res 16, 375-380
3. Antonelli, G, Giannelli, G., Pistello, M., Maggi, F., Vatterom, L., Currenti, M., Del Vecchio, S., Roffi, L., Pastore, G. and Dianzani, F. (1994). Clinical significance of recombinant interferon-α2 neutralizing antibodies in hepatitis patients. J. IFN & Cytokine Res. 14, 211-213.
4. Belardelli, F and Gresser, I, (1996). The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunology Today 17, 369-372.
5. Benoît, P., Maguire, D., Plavec, I , Kocher, H., Tovey, M. and Meyer, F. (1993) A monoclonal antibody to recombination human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega, Detection of heterogeity of the cellular type I IFN receptor. J. Immunol. 150, 707-716.
6. r protein kinase by poliovirus requires RNA J. Virol. 67, 791-800.
7. Blackman, M.J. and Morris, A.G. (1985). The effect of interferon treatment of targets on susceptibility to cytotoxic T-lymphocyte killing: augmentation of allogenic killing: augmentation of allogenic killing and virus-specific killing relative to viral antigen expression. Immunology 56, 451-457.
8. Bukowski, J.F. and Welsh, R.M. (1985). Inability of inerferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo. J. Exp. Med. 161, 257-262.
9. Cohen, B., Peretz, D., Vaiman, D., Benech, P. and Chebath, J. (1988). Enhancer-like interferon responsive sequences of the human and murine (2′-5′) oligoadenylate synthetase gene promoters. EMBO J. 7, 1411-1419.
10. Cross, J.C. and Roberts, M.R. (1991). Constitutive and trophoblast-specific expression of a class of bovine interferon genes. Proc. Natl. Acad. Sci. USA 88, 3817-3821.
11. D'Cunha, J., Knight, E.Jr., Haas, A.L., Truitt, R.L. and Borden, E.C. (1996). Immunoregulators properties of ISG15, an interferon-induced cytokine. Proc. Natl. Acad. Sci. USA 93, 211-215.
12. Dale, T.C., Imam, A.M.A., Kerr, I.M. and Stark, G.R. (1989a). Rapid activation by interferon α of a latent DNA-binding protein present in the cytoplasm of untreated cells. Proc. Natl. Acad. Sci. USA 86, 1203-1207.
13. Dale, T.C., Rosen, J.M., Guille, M.J., Lewin, A.R., Porter, A.G.C., Kerr, I.M. and Stark, G.R. (1989b). Overlapping sites for constitutive and induced DNA binding factors involved in interferon-stimulated transcription. EMBO J. 8, 831-839.
14. Dandoy, F., Ketley, K.A., De Maeyer-Guignard, J., De Maeyer, E. and Pitha, P.M. (1984), Linkage analysis of the murine interferon-α locus on chromosome 4. J. Exp. Med. 160, 294-302.
15. Darnell, J.E.Jr., Kerr, I.M. and Stark, G.R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins. Science 264, 1415-1421.
16. De Maeyer, E. and Dandoy, F. (1987). Linkage analysis of the murine interferon alpha locus on chromosome 4. J. Hered. 78, 143-146.
17. De Maeyer, E. and Dandoy, F. (1987). Linkage analysis of the murine interferon alpha locus (Ifa) on chromosome 4, Heredity 78, 143-146.
18. De Maeyer, E., De Maeyer-Guignard, J. and Vandeputte, M. (1975). Inhibition by interferon of delayed-type hypersensibility in the mouse. Proc. Natl. Acad. Sci. USA 72, 1753-1757.
19. De Maeyer-Guignard, J. and De Maeyer, E. (1985). Natural antibodies to interferon alpha and interferon beta are a common feature of inbred mouse strains. J. Immunol. 136, 1708-1711.
20. De Maeyer-Guignard, J., Cachard, A and De Maeyer, E. (1975). Delayed-type hypersensibility to sheep red blood cells: inhibition of sensitization by interferon. Science 190, 574-576.
21. De Maeyer-Guignard, J., Cachard, A. and De Maeyer, E. (1980). Electrophoretically pure mouse interferon has priming but no blocking activity in poly (I.C.)-induced cells. Virology 102, 222-225.
22. De Maeyer-Guignard, J., Cachard-Thomas, A. and De Maeyer, E. (1984). Naturally occurring anti-interferon antibodies in Lou/c rats. J. Immunol. 133, 775-778
23. Diaz, M.O., Pomykala, H.M., Bohlander, S.K., Maltepe, E., Malik, K., Brownstein, B. and Olopade, O.I. (1994). Structure of the human type I interferon gene cluster determined from a YAC clone contig Genomics 22, 540-552.
24. Dipaola, M., Smith, T., Ferencz-Biro, K., Liao, M -J and Testa, D. (1994). Interferon-α2 produced by normal human leukocytes is predominantly interferon-α2b. J. IFN & Cytokine Res. 14, 325-332.
25. Edwards, B S., Merrin, J.A., Fuhlbridge, R.C. and Borden, E.C. (1985). Low doses of interferon alpha result in more effective clinical natural killer cell activation J. Clin. Invest. 75, 1908-1913.
26. Ezekowitz, R.A.B , Phil, D., Mulliken, J B, and Folkman, J. (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med. 326, 1456-1463.
27. Fan, C -M and Maniatis, T. (1989). Two different virus-inducible elements are required for human 3-interferon gene regulation. EMBO J. 8, 101-110.
28. Farci, P., Mandas, A., Coiana, A., Lai, M.E., Desmet, V., Van Eyken, P., Gibo, Y., Caruso, L., Scaccabarozzi, S., Cricuolo, D., Ryff, J.-C. and Balestrieri, A. (1994). Treatment of chronic hepatitis D with interferon alfo-2a. N. Engl. J. Med. 330, 88-94.
29. Feng, G S., Chong, K., Kumar, A. and Williams, B.R.G. (1992). Identification of double-stranded-RNA binding domains in the interferon-induced soluble stranded RNA-activated p68 kinase. Proc Natl. Acad. Sci. USA 89, 5447-5451.
30. Foster, G.R., Rodrigues, O., Ghouze, F., Schulte-Frohlinde, E., Testa, D., Liao, M.J., Stark, G.R., Leadbeater, L. and Thomas, H.C. (1996). J. IFN and Cytokine Res. 16, 1027-1033.
31. Fradelizi, D. and Gresser, I. (1982). Interferon inhibits the regeneration of allospecific suppressor T lymphocytes. J. Exp. Med. 155, 1610-1622.
32. Fridman, W.H., Gresser, I., Bandu, M.T., Aguet, M. and Neauport-Sautes, C., (1980). Interferon enhances the expression of Fcγ receptors. J. Immunol. 124, 2436-2441.
33. Fu, X.Y. (1992) . A transcription factor with SH2 and SH3 domains is directly activated by an interferon α-induced cytoplasmic protein tyrosine kinase(s). Cell 70, 323-335.
34. Fu, X.Y., Kessler, D.S., Veals, S.A., Levy, D.E. and Darnell, J.E. Jr. (1990). ISGF3, the transcriptional activator induced by interferon α, consists of multiple interacting polypeptide chains. Proc. Natl. Acad. Sci. USA 87, 8555-8559.
35. Fu, X.Y., Schindler, C., Improta, T., Aebersold, R. and Darnell, J.E.Jr, (1992), The proteins of ISGF-3, the interferon α-induced transcriptional activator, define a gene family involved in signal transduction Proc. Natl. Acad. Sci. USA 89, 7840-7843.
36. Fujita, T., Kimura, Y., Miyamoto, M., Barsoumian, E.L. and Taniguchi, T. (1989a). Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor. IRF-1. Nature 337, 270-272.
37. Fujita, T., Miyamoto, M., Kimura, Y., Hammer, J. and Taniguchi, T. (1989b). Involvement of a cis-element that binds an H2TF-INFκB like factor(s) in the virus-induced interferon-β gene expression. Nucleic Acids Res. 17, 3335-3346.
38. Fujita, T., Reis, L.F.L., Watanabe, N., Kimura, Y , Taniguchi, T and Vilcek, J (1989c). Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways Proc. Natl. Acad. Sci. USA 86, 9936-9940.
39. Galabru, J., Katze, M.G., Robert, N. and Hovanessian, A.G. (1989). The binding of double-stranded RNA and adenovirus VA1 RNA to the interferon induced protein kinase. Eur. J Biochem. 178, 581-589.
40. Gessani, S., Belardelli, F , Pecorelli, A., Puddu, P. and Baglioni, C. (1989). Bacterial lipopolysaccharide and gamma interferon induce transcription of beta interferon mRNA and interferon secretion in murine macrophages. J. Virol. 63, 2785-2789.
41. Goodbourn, S., Zinn, K. and Maniatis, T. (1985). Human β-interferon gene expression is regulated by an inducible enhancer element. Cell 41, 509-520.
42. Gresser, I. (1972). Antitumor effects of interferon. Adv. Cancer Res. 16, 97-140.
43. Gresser, I. (1984), Role of interferon in resistance to viral infection in vivo. In: Interferon 2. Interferons and the Immune System (eds J. Vilcek and E. De Maeyer), Elsevier Science Publishers, Amsterdam, pp 221-247.
44. Gribaudo, G , Lembo, D., Cavallo, G., Landolfo, S. and Lengyel, P. (1991). Interferon action. Binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J. Virol. 65, 1748-1757.
45. Hansen, T.R., Leaman, D.W., Cross, J.C., Mathialagan, N., Bixby, J.A, and Roberts, R.M. (1991). The genes for the trophoblast interferons and the related interferon-α II possess distinct 5′-promoter and 3′-flanking sequences. J Biol. Chem. 266, 3060-3067.
46. Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T. and Taniguchi, T. (1989). Structurally similar but functionally distinct factors. IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58, 729-739.
47. Herberman, R.B., Ortaldo, J.R., Mantovani, A., Hobbs, D.S., Kung, H.F. and Pestka, S. (1982). Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. Cell Immunol. 67, 160-167.
48. Hiscott, J., Alper, D., Cohen, L., Leblanc, J.F., Sportza, L., Wong, A. and Xanthoudakis, S. (1989). Differential expression of human interferon genes. J. Virol. 63, 2557-2566.
49. Hiscott, J., Cantell, K. and Weissmann, C. (1984). Differential expression of human interferon genes. Nucleic Acids Res. 12, 3727-3746.
50. Hovanessian, A.G., Svab, J., Marie, I., Robert, N., Chamaret, S. and Laurent, A.G. (1988). Characterization of 69- and 100-kDa forms of 2-5A-synthetase from interferontreated human cells. J. Biol. Chem. 263, 4945-4949.
51. Hug, H., Costa, M., Staeheli, P., Aebi, M. and Weissmann, C. (1988). Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter. Mol. Cell. Biol. 8, 3065-3079.
52. Ichii, Y., Fukunaga, R., Shiojiri, S. and Sokawa, Y. (1986), Mouse 2-5A synthetase cDNA: nucleotide sequence and comparison to human 2-5A synthetase. Nucleic Acids Res. 14, 101-17.
53. Imam, A.M.A., Ackrill, A.M., Dale, T.C., Kerr, I.M. and Stark, G.R. (1990). Transcription factors induced by interferon α and γ. Nucl. Acids Res. 18, 6573-6580.
54. Isaacs, A. and Lindenmann, J. (1957). Virus interference. I. The interferon. Proc. R. Soc. (London), Ser. B 147, 258-273.
55. Jacobs, B.L. and Langland, J.O. (1996). When two strands are better than one: the mediators and modulators of the cellular responses to ds-RNA Virology 219, 339-349.
56. Jacobs, L., O'Malley, J., Freeman, A. and Ekes, R. (1981). Intrathecal interferon reduces exacerbations of multiple sclerosis. Science 214, 1026-1028.
57. Kelley, K.A. and Pitha, P.M. (1985a), Characterization of a mouse interferon gene locus. I. Isolation of a cluster of four α interferon genes. Nucleic Acids Res. 13, 805-823.
58. Kelley, K.A and Pitha, P.M. (1985b). Characterization of a mouse interferon gene locus. II. Differential expression of α-interferon genes. Nucleic Acids Res. 13, 825-839.
59. Kessler, D.S., Veals, S.A., Fu, X.Y. and Levy, D.E. (1990) Interferon-α regulates nuclear translocation and DNA-binding affinity of ISGF3 Genes & Development 4, 1753-1765
60. Kita, M., Tanaka, K., Uoshima, N., Kobayashi, Y., Ozawa, M., Kondo, M. and Immanishi, J. (1997). Determination of interferon-α2 allele composition in the genomic DNA from Healthy volunteers and leukemic patients in Japan. J. IFN & Cytokine Res. 17, 135-140.
61. Knobler, R.L., Breenstein, J.I., Johnson, K.P., Lublin, F D., Panitch, H.S., Conway, K., Grant-Gorsen, S.V., Muldoon, J., Marcus, S.G., Wallenberg, J.C., Williams, G.J. and Yoshizawa, C.N. (1993). Systemic recombinant human interferon-β treatment of relapsing-remitting multiple sclerosis: Pilot study analysis and six-year follow-up. J. IFN Res. 13, 333-340.
62. Knop, J., Stremmer, R., Neumann, C., De Maeyer, E. and Macher, E. (1982). Interferon inhibits the suppressor T cell response of delayed-type hypersensitivity. Nature 296, 775-776.
63. Knop, J , Taborksi, B. and De Maeyer-Guignard, J. (1987) Selective inhibition of the generation of T suppressor cells of contact sensitivity in vitro by interferon. J. Immunol. 138, 3684-3687.
64. Koromilas, A E., Roy, S., Barbe, G.N., Katze, M.G. and Sonenberg, N. (1992). Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257, 1685-1689.
65. Kumar, A., Haque, J., Lacoste, J., Hiscott, J. and Williams, B.R. (1994). Ds-RNA dependent protein kinase activates transcription factor NF-kappaB by phophorylating I kappaB. Proc. Natl. Acad. Sci. USA 91, 6288 6292.
66. Kurosaki, M., Enomoto, N., Murakami, T., Sakuma, I., Asahina, Y., Yamamoto, C., Okeda, T., Tozuka, S , Izumi, N., Marumo, F. and Sato, C. (1997). Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-β therapy. Hepathology 25, 750-753.
67. Lee, N., Ni, D., Brissette, R., Chou, M., Hussain, M., Gill, D.S., Liao, M.-J. and Testa, D. (1995). Interferon-a2 variants in the human genome. J. IFN & Cytokine Res. 15, 341-349.
68. Lee, S.B. and Esteban, M. (1994). The IFN-induced ds-RNA activated PKR-induced apoptosis Virology 199, 491-496.
69. Lefèvre, F. and Boulay, V. (1993). A novel and atypical type one interferon gene expressed by trophoblast during early pregnancy. J. Biol. Chem. 268, 19760-19768.
70. Lenardo, M.J. and Baltimore, D. (1989). NF-κB a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58, 227-229.
71. Lenardo, M.J , Fan, C.-M., Maniatis, T. and Baltimore, D. (1989). The involvement of NF-κB in β-interferon gene regulation reveals its role as widely inducible ediator of signal transduction. Cell 57, 287-294.
72. Lengyel, P. (1982). Biochemistry of interferons and their actions. Ann. Rev. Biochem. 51, 251-282.
73. Levy, D.E., Kessler, D.S., Pine, R. and Darnell. J.E.Jr. (1989). Cytoplasmic activation of ISGF3, the positive regulator of interferon-α-stimulated transcription, reconstituted in vitro. Genes & Development 3, 1362-1371.
74. Levy, D.E., Kessler, D.S., Pine, R., Reich, N. and Darnell, J.E.Jr. (1988). Interferon-induced nuclear factors that binds a shared promoter element correlate with positive and negative transcriptional control. Genes Development 2, 383-393.
75. Ling, L.E., Zafari, M., Reardon, D., Brickelmeier, M., Goelz, S.E. and Benjamin, C.D. (1995), Human type I interferon receptor, IFNAR, is a heavily glycosylated 120-130 kD membrane protein. J. IFN & Cytokine Res. 15, 55-61.
76. Liu, L., Leaman, D.W. and Roberts, R.M. (1996). The interferon-τ genes of the giraffe, a nonbovid species. J. IFN & Cytokine Res. 16, 949-951.
77. Lutfalla, G., Gardiner, K., Proudhon, D., Vielh, E. and Uze, G. (1992). The structure of the human interferon α/β receptor gene. J. Biol. Chem. 267, 2802-2809
78. Lutfalla, G., Roeckel, N., Mogensen, K.E., Mattei, M.-G. and Uze, G. (1990). Assignment of the human interferon-α receptor gene to chromosome 21q22.1 by in situ, hybridization. J. Interferon Res. 10, 515-517.
79. MacDonald, N.J., Kuhl, D., Maguire, D., Naf, D., Gallant, P., Goswamy, A., Hug, H., Bueler, H., Chaturvedi, M., de la Fuente, J., Ruffner, H., Meyer, F. and Weissmann, C. (1990). Different pathways mediate virus inducibility of the human IFN-α1 and IFN-β genes. Cell 60, 767-779.
80. McKendry, R., John, J., Flavell, D., Muller, M., Kerr, I.M. and Stark, G.R. (1991). High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc. Natl. Acad. Sci. USA 88, 11455-11459
81. Meurs, D.F., Galabru, J., Barber, G N., Katze, M.G. and Hovanessian, A.G. (1993). Tumor suppressor function of the interferon-induced ds-RNA activated protein kinase. Proc. Natl. Acad. Sci. USA 90, 232-236.
82. Miyamoto, M., Fujita, T., Kumura, Y , Maruyama, M., Harada, H., Sudo, Y., Miyata, T. and Taniguchi, T. (1988). Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell 54, 903-913.
83. Mobraaten, L.E., De Maeyer, E. and De Maeyer-Guignard, J. (1973). Prolongation of allograft survival in mice by inducers of interferon. Transplantation 16, 415-420.
84. Moore, R.N., Larsen, H.S., Horohov, D.W. and Rouse, B T. (1984). Endogenous regulation of macrophage proliferative expansion by CSF-induced interferon. Science 223, 178-181.
85. Müller, U., Steinhoff, U., Reis, L.F.L., Hemmi, S., Pavlovic, J., Zinkernagel, R.M. and Aguet, M. (1994). Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921.
86. Nishiguchi, S., Kuroki, T., Nakatani, S., Morimoto, H , Takeda, T., Nakajima, S., Shiomi, S., Seki, S., Kobayashi, K. and Otam, S. (1995). Randomised trail of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346, 1051-1055.
87. Nolte, K.U., Kakschies, D., Pestka, S. and Von Wusso, P. (1994), Different specificities of SLE-derived and therapy-induced interferon-a antibodies. J. IFN & Cytokine Res. 14, 197-199.
88. Noronha, A., Toscas, A. and Jensen, M.A. (1990). Interferon beta augments suppressor cell function in multiple sclerosis. Ann. Neurol. 27, 207-210.
89. Palombella, V.J. and Maniatis, T. (1992). Inducible processing of interferon regulatory factor-2. Mol. Cell. Biol. 12, 3325-3336.
90. Panitch, H.S. (1992). Interferon in multiple sclerosis. A review of the evidence. Drugs 44, 946-962.
91. Paty, D.W., Li, D.K.B., the UBC MS/MRI Study Group, and the IFNB Multiple Sclerosis Study Group (1993). Interferon beta-1β is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized doudle-blind, placebo-controlled trial. Neurology 43, 662-667.
92. Pine, R. (1992). Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection, J. Virol. 66, 4470-4478.
93. Pine, R., Decker, T., Kessler, D.S., Levy, D.E. and Darnell, J.E.Jr. (1990). Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2: (IRF-1) can bind to the promoters of both beta interferon- and interferon- stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 10, 2448-2457.
94. Reich, N.C. and Darnell, J.E.Jr. (1989). Differential binding of interferon-induced factors to an oligonucleotide that mediates t ranscriptional activation. Nucleic Acids Res. 17, 3415-3424.
95. Reis, L.F.L., Lee, T.H. and Vilceck, J. (1989). Tumor necrosis factor acts synergistically with autocrine interferon-β and increases interferon-β mRNA levels in human fibroblasts. J. Biol. Chem. 264, 16351-16354.
96. Rinderknecht, E., O'Connor, B.H. and Rodriguez, H. (1984). Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation. J. Biol. Chem. 259, 6790-6797.
97. Roberts, M.R., Cross, J.C. and Leaman, D.W. (1991). Unique features of the trophoblast interferons Pharmac. Ther. 51, 329-345
98. Roy, S., Agy, M., Hovanessian, H.G., Sonenberg, N. and Katze, MG. (1991). The integrity of the stem structure of human immunodeficiency virus type I Tat-responsive sequence RNA is required for interaction with the interferon-induced 68,000-Mγ protein kinase. J. Virol 65, 632-640.
99. Rutherford, M.N., Kumar, A., Nissim, A., Chebath, J. and Williams, B.R.G. (1991). The murine 2-5A synthetase locus: three distinct transcripts from two linked genes. Nucl. Acids Res. 19, 1917-1924.
100. Ryals, J., Dierks, P., Ragg, H. and Weissmann, C. (1985). A 46-nucleotide promoter segment from an interferon alpha gene renders an unrelated promoter inducible by virus. Cell 41, 497-507.
101. Samuel, C.E , Duncan, G.S., Knutson, G.S. and Hershey, J.W.B. (1984). Mechanisms of interferon action. J. Biol. Chem 259, 13451-13457.
102. Schindler, C., Fu, X.Y , Improta, T., Aebersold, R. and Darnell, J.E.Jr (1992). Proteins of transcription factor ISGF-3: One gene encodes the 91 and 84 kDa ISGF-3 proteins that are activated by interferon. Proc Natl. Acad. Sci. USA 89, 7836-7839.
103. Seif, I. and De Maeyer-Guignard, J. (1986). Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha9. Gene 43, 111-121.
104. Sekellick, M.J. and Marcus, P.I. (1982). Interferon induction by viruses. Virology 117, 280-285
105. Shirayoshi, Y., Burke, P.A., Appella, E. and Ozato, K. (1988). Interferon-induced transcription of a major histocompatibility class I gene accompanies binding of inducible factors to the interferon consensus sequence, Proc. Natl. Acad. Sci, USA 85, 5884-5888.
106. Sims, S.H., Cha, Y., Romine, M.F., Gao, P.Q., Gottlieb, K. and Deisseroth, A.B. (1993). A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor I gene promoter, Mol. Cell. Biol. 13, 690-702.
107. Staeheli, P. (1990). The Mx locus In Advances in Virus Research 38, 147-200. Academic Press, London.
108. Tada, Y., Ho, A., Matsuyama, T. and Mak, T.W. (1997). Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. Exp. Med. 185, 231-238.
109. The IFNB Multiple Sclerosis Study Group (1993). Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 655-661.
110. Tough, D.F., Borrow, P. and Sprent, J. (1996). Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947-1950.
111. Uzė, G., Lutfalla, G., Bandu, M.T., Proudhon, D., Mogensen, K.E. (1992). Behavior of a cloned murine interferon receptor expressed in homospecific or heterospecific background. Proc. Natl. Acad. Sci. USA 89, 4774-4778.
112. Uzé, G., Lutfalla, G. and Gresser, I. (1990). Genetic transfer of a functional human interferon receptor into mouse cells: cloning and expression of its DNA. Cell 60, 225-234.
113. Uzé, G., Lutfalla, G. and Mogensen, K. E. (1995), α and β interferons and their receptor and their friends and relations. J. IFN & Cytokine Res. 15, 3-26.
114. Veals, S.A., Schindler, C., Leonard, D., Fu, X.Y., Aebersold, R., Darnell, J.E.Jr. and Levy, D.E. (1992). Subunit of an alpha interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol. Cell. Biol. 12, 3315-3324.
115. Vieillard, V., Lauret, E., Rousseau, V. and De Maeyer, E. (1994). Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon-beta. Proc Natl. Acad. Sci. USA 91, 2689-2693.
116. Virelizier, J.L. and Gresser, I. (1978). Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. J. Immunol. 120, 1616-1619.
117. Von Wussow, P., Hehlmann, R., Hochhaus, T., Jakschies, D , Nolte, K.U., Prümmer, O , Ansari, H., Hasford, J., Heimpel, H. and Deicher, H. (1994). Roferon (rIFN-α2a) is more immunogenic than intron A (rIFN-α2b) in patients with chronic myelogenous leukemia. J. IFN & Cytokine Res. 14, 217-219.
118. Xanthoudakis, S., Cohen, L. and Hiscott, J. (1989). Multiple protein-DNA interactions within the human interferon-beta regulatory element, J. Biol. Chem. 15, 1139-1145.
119. Zeuzem, S , Lee, J -H and Roth, W.K. (1997). Mutations in the nonstructural 5A gene of european hepatitis C virus isolates and response to interferon alfa. Hepatology 25, 740-744.
120. Zinkernagel, R.M. and Doherty, P.C. (1974). Restriction of in vitro T cell-mediated cytotoxicity in LCM within a syngeneic or semiallogeneic system. Nature 224, 701-702.